Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 variant in China's sichuan population

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 1, 2005, Pages 38-43

  Ma, Liying ^a,b   Dudoit, Yasmine ^a   Tran, Ton ^d   Xing, Hui ^b   Chen, Jianping ^b   Pancino, Gianfranco ^c   Bismuth, Georges ^e   Debré, Patrice ^a   Shao, Yiming ^b   Theodorou, Ioannis ^a   Capoulade Métay, Corinne ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c INSTITUT PASTEUR   (France)

^d PASTEUR INSTITUTE   (Viet Nam)

^e INSTITUT COCHIN   (France)

Author keywords

CCR5; Chemokine; China; HIV 1; Polymorphism

Indexed keywords

ARGININE; CHEMOKINE RECEPTOR CCR5; LYSINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; ASIAN; CAUCASIAN; CCR5 GENE; CHINA; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; LIGAND BINDING; NEGRO; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR GENE; RECEPTOR INTRINSIC ACTIVITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CHEMOKINES, CC; CHINA; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION; RANTES; RECEPTORS, CCR5; TRANSFECTION; VARIATION (GENETICS);

EID: 20944435640     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000158761.71165.e9     Document Type: Article

References (27)

1. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 1993;261:1179-1181.
2. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature. 1996;382:722-725.
3. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377.
4. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR5δ32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS. 1997;11:F73-F78.
5. Theodorou I, Meyer L, Magierowska M, et al. HIV-1 infection in an individual homozygous for CCR5δ32. The SEROCO Study Group. Lancet. 1997;349:1219-1224.
6. Libert F, Cochaux P, Beckman G, et al. The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet. 1998;7:399.
7. Martinson JJ, Chapman NH, Rees DC, et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet. 1997;16:100-103.
8. Cohen J. Poised for takeoff? Science. 2004;304:1430-1432.
9. Shao Y. HIV/AIDS: perspective on China. AIDS Patient Care STDS. 2001;15:431-432.
10. UNAIDS. Report on the Global HIV/AIDS Epidemic 2004. Geneva, Switzerland,
11. Ruan Y-H, Hong K-X, Liu S-Z, et al. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol. 2004;10:1589-1593.
12. Combadiere C, Ahuja SK, Tiffany HL, et al. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β, and RANTES. J Leukoc Biol. 1996;60: 147-152.
13. Merat R, Raoul H, Leste-Lasserre T, et al. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1. J Virol. 1999;73:5698-5706.
14. Zheng B-J, Zhao X-Y, Zhu N-S, et al. Polymorphisms of CCR5 gene in a southern Chinese population and their effects on disease progression in HIV infections. AIDS. 2002;16:2480-2482.
15. Capoulade-Metay C, Ma L, Truong XL, et al. New CCR5 variants associated with reduced HIV coreceptor function in South-East Asia. AIDS. 2004;18:2243-2252.
16. Magierowska M, Lepage V, Truong Xuan L, et al. Novel variant of the CCR5 gene in a Vietnamese population. Microbes Infect. 1999;2:123-124.
17. Ansari-Lari A, Liu X-M, Metzkler ML, et al. The extent of genetic variation in the CCR5 gene. Nat Genet. 1997;16:221-222.
18. Carrington M, Kissner T, Gerrard B, et al. Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet. 1997;61:1261-1267.
19. Blanpain C, Lee B, Tackoen M, et al. Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood. 2000;96:1638-1645.
20. Petersen DC, Kotze MJ, Zeier MD, et al. Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay. AIDS. 2001;15:171-177.
21. Fauci AS. Resistance to HIV-1 infection: it's in the genes. Nat Med. 1996; 2:966-967.
22. Alkhatib G, Combadiere C, Broder CC, et al. A. CC CKR5: a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272[5270]:1955-1958.
23. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657-700.
24. Feng T, Ni A, Yang G, et al. Distribution of the CCR5 gene 32-base pair deletion and CCR5 expression in Chinese minorities. J Acquir Immune Defic Syndr. 2003;32:131-134.
25. Zhou N, Luo Z, Hall JW, et al. Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction. Eur J Immunol. 2000;30:164-173.
26. Dragic T, Trkola A, Lin SW, et al, Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J Virol. 1998;72:279-285.
27. Howard OM, Shirakawa AK, Turpin JA, et al. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function. J Biol Chem. 1999;274:16228.